PyInvesting

Market research

603739.SHG Qingdao Vland Biotech INC

SHG CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
3B
P/E ratio
39.06
Analyst target
16
Dividend yield
0.8%
Beta
0.36

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Qingdao Vland Biotech INC is currently in a long term uptrend where the price is trading 3.6% above its 200 day moving average.

From a valuation standpoint, the stock is 59.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.

Qingdao Vland Biotech INC's total revenue rose by 17.5% to $261M since the same quarter in the previous year.

Its net income has increased by 90.6% to $29M since the same quarter in the previous year.

Finally, its free cash flow fell by 55.4% to $-31M since the same quarter in the previous year.

Based on the above factors, Qingdao Vland Biotech INC gets an overall score of 4/5.